U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
A new study shows risks for premature death associated with CUD. Others show increased memory problems, CUD, depression, bipolar illness, suicide, and addictions in youth users.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback